Able to understand and comply with the study procedures, understand the risks involved in the study, and provide written informed consent before the first study-specific procedure; specifically able to comply with the PK assessment schedule during the first 2 treatment cycles.
Subject is able to understand and willing to sign the ICF, according to institutional standards, prior to the initiation of any study related procedures;
Able to understand the study procedures and agree to participate in the study by providing written informed consent
Understand study design, risks, and benefits and have signed informed consent
Is able to provide written informed consent (in English) to participate in the study and able to understand the procedures and study requirements
Participants must be able to understand and sign a written informed consent form and understand the importance of adherence to study treatment and protocol; in addition, participants must demonstrate a willingness to follow all study requirements, including the concomitant medication restrictions, throughout the study
Patients must give written informed consent prior to initiation of therapy, in keeping with the policies of the institution. Patients with a history of major psychiatric illness must be judged able to fully understand the investigational nature of the study and the risks associated with the therapy.
Patients must give written informed consent prior to initiation of therapy, in keeping with the policies of the institution. Patients with a history of major psychiatric illness must be judged able to fully understand the investigational nature of the study and the risks associated with the therapy
Subject must understand risks and benefits of the protocol and be able to give informed consent
Able to understand and comply with the study procedures, understand the risks involved in the study, and provide written informed consent before the first study-specific procedure
Patient or legally appropriate proxy must be able to understand study instructions and sign consent
Able to understand, and the willingness to give, informed consent for the study
Patients must give written informed consent prior to initiation of therapy, in keeping with the policies of the institution; patients with a history of major psychiatric illness must be judged able to fully understand the investigational nature of the study and the risks associated with the therapy
Able to read or understand and give informed consent.
The patient, or their representative, is able to understand the study and is willing to consent to participation in the study.
Part 1: be able to understand the description of the study and give written informed consent
Part 2: able to understand the recommendations for participation in the study
Able to understand and comply with the protocol and study procedures, understand the risks involved in the study, and provide written informed consent before any study-specific procedure is performed.
Subjects must be able to understand the potential risks and benefits of the study, and be able to read and give written informed consent
Be able to understand the study procedures, agree to participate in the study program, and voluntarily provide written Informed Consent
Subjects must be able to understand the potential risks and benefits of the study and must be able to read and provide written, informed consent for the study
Subjects must be able to understand the potential risks and benefits of the study and must be able to read and provide written, informed consent for the study
Must be able to read and understand informed consent
Patients must be female, be ? 18 years of age, be able to understand the study procedures, and agree to participate in the study by providing written informed consent.
Able to understand the study procedures and agree to participate in the study by providing written informed consent Cohort Specific Inclusion Criteria:
Subjects willing and able to give written informed consent to participate in the study and to adhere to the procedures stated in the protocol, or legally acceptable representative willing and able to give written informed consent on behalf of the subject for minors, unconscious adults and those incapable of consenting themselves due to their medical condition, or included as permitted by local regulatory authorities, IRB/IECs or local laws.
Subject is able to read, understand, and sign a written Informed Consent to participate in the study.
Able to understand the description of the study and willing to participate
YBCS: Able to consent to the study
HCP: Able to consent to the study
Able to understand the description of the study and willing to participate
Be able to understand the description of the study and give written informed consent
Patient has been informed of the investigational nature of this study and has given written Informed Consent and is able to adhere to dosing and visit schedules and meet all study requirements
Able to fully understand and participate in the informed consent process
Patients who are able to understand and give consent to participating in the study
Patient is able to understand and give consent to participation in the study.
Patients who in the judgment of the investigators and/or consenting professional, are able to understand the purpose of the study and provide informed consent will be included
Able to understand study requirements
Unwilling or unable to provide informed consent; only individuals (aged 18 or over) who can understand and give informed consent will be approached to participate in this study; individuals who are considered to be mentally disabled will not be recruited for this study; all subjects must understand and be able to give informed consent; we will not be using specific methods to assess decisional capacity; economically disadvantaged persons will not be vulnerable to undue influence, as this study offers no compensation; all individuals will be told that their choice regarding study participation will in no way change their access to clinical care; this should negate any undue influence or coercion; children, fetuses, neonates, or prisoners\r\nare not included in this research study; the menopausal status of the study participant will be reviewed during the screening process by examining the patient’s chart, women of childbearing potential will have a serum or urine pregnancy test at the time of screening
Only individuals (aged 18 or over) who can understand and give informed consent will be eligible to participate in this study
Only individuals who can understand and give informed consent will be eligible to participate in this study
Adults with a suspected or confirmed lymphoma diagnosis and:\r\n* Who will undergo clinically indicated procedure potentially allowing for excess or discarded clinical specimens\r\n* Who must be able to understand and sign an informed consent
Inability to understand the risks and benefits of the study
Able to understand and comply with study procedures, understand the risks involved, and provide written informed consent.
Only individuals who can understand and give informed consent will be eligible to participate in this study; individuals who are considered to be mentally disabled will not be recruited for this study; all subjects must understand and be able to give informed consent; we will not be using specific methods to assess decisional capacity; all individuals will be told that their choice regarding study participation will in no way change their access to clinical care; this should negate any undue influence or coercion; children, fetuses, neonates, or prisoners are not included in this research study; women of child-bearing potential will have a urine pregnancy test at the time of screening
The patient must be able to communicate and understand/complete forms/instructions, and be able to provide informed written consent prior to enrollment; patients may have the assistance of an interpreter or surrogate when completing forms/surveys as needed
Participant must be able to understand and give consent to participate in the study